Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Ondansetron lingual spray (Zensana) (BA-029)
print preview
bookmark
share with colleague
General Information
Company
NovaDel Pharma Inc.
Description
Ondansetron lingual spray
Molecular Target
Serotonin (5-HT3) receptor
Mechanism of Action
Serotonin (5-HT3) receptor antagonist
Latest Stage of Development
Preclinical
Indication
Emesis
Partner
BioAlliance Pharma S.A.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information